1.46
                                            
            Intercure Ltd stock is traded at $1.46, with a volume of 66,457.
            It is up +4.29% in the last 24 hours and down -9.88% over the past month.
            Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
        
        See More
    Previous Close:
              $1.40
            Open:
              $1.43
            24h Volume:
                66,457
            Relative Volume:
              1.03
            Market Cap:
                $76.32M
            Revenue:
              $118.18M
            Net Income/Loss:
              $5.99M
            P/E Ratio:
              11.07
            EPS:
                0.1319
            Net Cash Flow:
                $-12.91M
            1W Performance:
              -0.68%
            1M Performance:
              -9.88%
            6M Performance:
                -8.75%
            1Y Performance:
              -16.33%
            Intercure Ltd Stock (INCR) Company Profile
Compare INCR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                INCR
                            
                             
                        Intercure Ltd 
                           | 
                    1.46 | 76.32M | 118.18M | 5.99M | -12.91M | 0.1319 | 
| 
                         
                          
                                ZTS
                            
                             
                        Zoetis Inc 
                           | 
                    144.35 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 | 
| 
                         
                          
                                TAK
                            
                             
                        Takeda Pharmaceutical Co Adr 
                           | 
                    13.42 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 | 
| 
                         
                          
                                HLN
                            
                             
                        Haleon Plc Adr 
                           | 
                    9.38 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 | 
| 
                         
                          
                                TEVA
                            
                             
                        Teva Pharmaceutical Industries Ltd Adr 
                           | 
                    20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 | 
| 
                         
                          
                                UTHR
                            
                             
                        United Therapeutics Corp 
                           | 
                    438.66 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 | 
Intercure Ltd Stock (INCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change | 
|---|---|---|---|
| May-18-22 | Upgrade | Canaccord Genuity | Speculative Buy → Buy | 
Intercure Ltd Stock (INCR) Latest News
Volatility clustering patterns for InterCure Ltd.Bear Alert & Daily Market Momentum Tracking - newser.com
Using data models to predict InterCure Ltd. stock movementMarket Trend Report & Weekly Market Pulse Alerts - newser.com
InterCure acquires 28% stake in cannabis research firm Cannasoul - Investing.com
Real time scanner hits for InterCure Ltd. explainedMarket Activity Report & Technical Pattern Based Signals - newser.com
InterCure and Cannasoul Forge Strategic Partnership to Innovate Cannabis Therapeutics - TipRanks
Applying Wyckoff theory to InterCure Ltd. stockJuly 2025 PostEarnings & Technical Pattern Alert System - newser.com
InterCure (NASDAQ: INCR) signs Cannasoul collaboration; 28% stake, path to 51% - Stock Titan
Is InterCure Ltd. stock a buy in volatile markets2025 Growth vs Value & Daily Stock Trend Reports - newser.com
What technical charts say about InterCure Ltd. stockPortfolio Growth Summary & High Accuracy Swing Entry Alerts - newser.com
Does InterCure Ltd. stock trade at a discount to peersBuy Signal & Free Daily Entry Point Trade Alerts - newser.com
Why InterCure Ltd. stock attracts global investors2025 Stock Rankings & Reliable Trade Execution Plans - newser.com
News impact scoring models applied to InterCure Ltd.2025 Dividend Review & Daily Chart Pattern Signal Reports - newser.com
What sentiment indicators say about InterCure Ltd. stockEarnings Overview Report & Weekly Breakout Watchlists - newser.com
Is InterCure Ltd. stock recession proof2025 Price Momentum & Verified Trade Idea Suggestions - newser.com
Can InterCure Ltd. stock beat market expectations this quarterMarket Movement Recap & AI Driven Price Forecasts - newser.com
Will InterCure Ltd. stock outperform international peersPortfolio Update Summary & AI Based Buy and Sell Signals - newser.com
Technical signs of recovery in InterCure Ltd.July 2025 Macro Moves & Reliable Price Breakout Signals - newser.com
Is it time to cut losses on InterCure Ltd.Dip Buying & Stepwise Trade Signal Implementation - newser.com
Analyzing drawdowns of InterCure Ltd. with statistical toolsQuarterly Profit Report & Growth Focused Entry Reports - newser.com
How InterCure Ltd. stock benefits from tech adoptionGlobal Markets & Community Trade Idea Sharing Platform - newser.com
Will InterCure Ltd. stock recover after recent dropDollar Strength & Free High Accuracy Swing Entry Alerts - newser.com
Can swing trading help recover from InterCure Ltd. lossesJuly 2025 Institutional & Safe Capital Investment Plans - newser.com
Will InterCure Ltd. price bounce be sustainableJuly 2025 PostEarnings & Community Verified Trade Signals - newser.com
What technical models suggest about InterCure Ltd.’s comebackPortfolio Return Report & Free Expert Approved Momentum Trade Ideas - newser.com
Is InterCure Ltd. stock cheap at current valuationWeekly Earnings Recap & Proven Capital Preservation Tips - newser.com
Sentiment analysis tools applied to InterCure Ltd.July 2025 Earnings & Verified High Yield Trade Plans - newser.com
Intercure Ltd Stock (INCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
        Open in Yahoo
        |
        Open in Google
            |
            Open in Finviz
        |
        Open in MarketWatch
            |
            Open in EDGAR    
        |
        Open in Reuters
    
    
                Cap:
                 
                  | 
                Volume (24h):